Sarepta Therapeutics to Present Company Overview at Upcoming Conferences

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 
Webcast Accessible via Sarepta Therapeutics Website 
CAMBRIDGE, MA -- (Marketwired) -- 11/19/13 --  Sarepta Therapeutics
(NASDAQ: SRPT), a developer of innovative RNA-based therapeutics,
announced today that it is scheduled to present at the following
investor conferences in December. Chris Garabedian, Sarepta's
president and chief executive officer, will be the presenter. 

--  Deutsche Bank BioFEST in Boston, MA on Monday, December 2, 2013 at
    5:10 p.m. Eastern Time.
--  Piper Jaffray 25th Annual Healthcare Conference in New York, NY on
    Wednesday, December 4, 2013 at 9:30 a.m. Eastern Time.

The presentations will be webcast live on the investor relations
section of the Sarepta Therapeutics website at and
will be archived under the events and presentations section following
the presentation for 90 days. Please connect to Sarepta's website
several minutes prior to the start of the broadcast to ensure
adequate time for any software download that may be necessary. 
About Sarepta Therapeutics 
Sarepta Therapeutics is focused on developing first-in-class
RNA-based therapeutics to improve and save the lives of people
affected by serious and life-threatening rare and infectious
diseases. The Company's diverse pipeline includes its lead program
eteplirsen, for Duchenne muscular dystrophy, as well as potential
treatments for some of the world's most lethal infectious diseases.
Sarepta aims to build a leading, independent biotech company
dedicated to translating its RNA-based science into transformational
therapeutics for patients who face significant unmet medical needs.
For more information, please visit us at 
Sarepta Investor Contact: 
Erin Cox 
Sarepta Media Contact:
Jim Baker
Press spacebar to pause and continue. Press esc to stop.